A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to investigate the efficacy, safety, and tolerability of camizestrant in combination with ribociclib in patients with ER+ HER2- BC who have not received any other systemic treatment for advanced disease. Participants will be treated within the trial until they discontinue the study treatment for any reason.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzony histologicznie lub cytologicznie rak piersi ER-dodatni i HER2-ujemny
- •Choroba zaawansowana lub przerzutowa, nienadająca się do operacji lub radioterapii ze względu na wyleczenie
- •Brak wcześniejszego leczenia systemowego (chemioterapii itp.) z powodu zaawansowanej choroby
- •Nowa choroba zaawansowana (IV stopień) lub nawrót po wcześniejszym leczeniu hormonalnym
- •Ogólny stan zdrowia na poziomie 0-1 (według skali ECOG)
- •Prawidłowe funkcjonowanie narządów i szpiku kostnego
- •Dla kobiet: negatywny test ciążowy, odpowiednia antykoncepcja lub postmenopauzalność
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 130 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (84)
Research Site
Duarte, United States
Research Site
Palo Alto, United States
Research Site
Marietta, United States
Research Site
Evanston, United States
Research Site
Edgewood, United States
Research Site
Louisville, United States
Research Site
Reno, United States
Research Site
Sioux Falls, United States
Research Site
Nashville, United States
Research Site
Fort Worth, United States
Research Site
Kingwood, United States
Research Site
Midlothian, United States
Research Site
Angers, France
Research Site
Bayonne, France
Research Site
Bobigny, France
Research Site
Caen, France
Research Site
Chambray-lès-Tours, France
Research Site
Grenoble, France
Research Site
Montpellier, France
Research Site
Nancy, France
Research Site
Nîmes, France
Research Site
Paris, France
Research Site
Pierre-Bénite, France
Research Site
Valenciennes, France
Research Site
Vandœuvre-lès-Nancy, France
Research Site
Villejuif, France
Research Site
Berlin, Germany
Research Site
Düsseldorf, Germany
Research Site
Freiburg im Breisgau, Germany
Research Site
Mönchengladbach, Germany
Research Site
München, Germany
Research Site
Paderborn, Germany
Research Site
Trier, Germany
Research Site
Velbert, Germany
Research Site
Aviano, Italy
Research Site
Bergamo, Italy
Research Site
Genova, Italy
Research Site
Milan, Italy
Research Site
Naples, Italy
Research Site
Gdansk, Poland
Research Site
Konin, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Poznan, Poland
Research Site
Przemyśl, Poland
Research Site
Wroclaw, Poland
Research Site
Cheonan-si, South Korea
Research Site
Daegu, South Korea
Research Site
Goyang-si, South Korea
Research Site
Hwasun-eup, South Korea
Research Site
Incheon, South Korea
Research Site
Seongbuk-Gu, South Korea
Research Site
Seongnam-si, South Korea
Research Site
Seongnam-si, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Songpa-gu, South Korea
Research Site
Suwon, South Korea
Research Site
Badajoz, Spain
Research Site
Badalona, Spain
Research Site
Barcelona, Spain
Research Site
Burgos, Spain
Research Site
Donostia / San Sebastian, Spain
Research Site
Huelva, Spain
Research Site
Jaén, Spain
Research Site
Las Palmas de Gran Canaria, Spain
Research Site
Majadahonda, Spain
Research Site
Málaga, Spain
Research Site
Murcia, Spain
Research Site
Oviedo, Spain
Research Site
Palma de Mallorca, Spain
Research Site
Pontevedra, Spain
Research Site
Pozuelo de Alarcón, Spain
Research Site
Santander, Spain
Research Site
Toledo, Spain
Research Site
Zaragoza, Spain
Research Site
Basel, Switzerland
Research Site
Liestal, Switzerland
Research Site
Rennaz, Switzerland
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.